{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T12:02:51Z","timestamp":1785067371951,"version":"3.55.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/j.neulet.2018.08.010","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T16:26:03Z","timestamp":1533918363000},"page":"35-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Positron emission tomography imaging of the \u03b3-aminobutyric acid system"],"prefix":"10.1016","volume":"691","author":[{"given":"Jan D.","family":"Andersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Matuskey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd J.","family":"Finnema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2018.08.010_bib0005","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0021-9258(19)50929-2","article-title":"Gamma-aminobutyric acid in brain: its formation from Glutamic acid","volume":"187","author":"Roberts","year":"1950","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0021-9258(19)50930-9","article-title":"Identification of gamma-aminobutyric acid in brain by the isotope derivative method","volume":"187","author":"Udenfriend","year":"1950","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0015","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1177\/1073858402238515","article-title":"Book review: GABA and glutamate in the human brain","volume":"8","author":"Petroff","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2018.08.010_bib0020","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4014\/jmb.1511.11037","article-title":"Co-localization of GABA shunt enzymes for the efficient production of gamma-aminobutyric acid via GABA shunt pathway in escherichia coli","volume":"26","author":"Pham","year":"2016","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0028-3908(71)90013-X","article-title":"Blood-brain barrier to H3-??-aminobutyric acid in normal and amino oxyacetic acid-treated animals","volume":"10","author":"Kuriyama","year":"1971","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2018.08.010_bib0030","doi-asserted-by":"crossref","first-page":"5662","DOI":"10.1073\/pnas.90.12.5662","article-title":"Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo","volume":"90","author":"Rothman","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2018.08.010_bib0035","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/appi.ajp.160.3.577","article-title":"Such as the occipital lobe [6]","volume":"160","author":"Sanacora","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0040","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0079-6123(06)60002-2","article-title":"GABA: homeostatic and pharmacological aspects","volume":"160","author":"Schousboe","year":"2007","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0045","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0031-6997(25)06840-1","article-title":"Structure and pharmacology receptor of subtypes AcidA","volume":"47","author":"Sieghart","year":"1995","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0050","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pharmthera.2006.03.006","article-title":"Molecular diversity, trafficking and subcellular localization of GABAB receptors","volume":"110","author":"Bettler","year":"2006","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.neulet.2018.08.010_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.tins.2006.11.001","article-title":"GABA sets the tempo for activity-dependent adult neurogenesis","volume":"30","author":"Ge","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0060","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0301-0082(02)00013-8","article-title":"Drug interactions at GABAA receptors","volume":"67","author":"Korpi","year":"2002","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","article-title":"International union of pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function","volume":"60","author":"Olsen","year":"2008","journal-title":"Update Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0031-6997(24)01363-2","article-title":"International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function","volume":"50","author":"Barnard","year":"1998","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0075","doi-asserted-by":"crossref","first-page":"795","DOI":"10.2174\/1568026023393507","article-title":"Subunit composition, distribution and function of GABA(A) receptor subtypes","volume":"2","author":"Sieghart","year":"2002","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0080","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","article-title":"Trace fear conditioning involves hippocampal alpha5 GABA(A) receptors","volume":"99","author":"Crestani","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2018.08.010_bib0085","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/cne.21115","article-title":"Synaptic and non-synaptic localization of GABA(A) receptors containing the \u03b15 subunit in the rat brain","volume":"499","author":"Serwanski","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0090","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0165-6147(00)89009-4","article-title":"Functional domains of GABAA receptors","volume":"16","author":"Smith","year":"1995","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0095","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00441-006-0284-3","article-title":"GABAA receptor diversity and pharmacology","volume":"326","author":"M\u00f6hler","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0100","first-page":"24","article-title":"Pharmacology of benzodiazepine receptors: an update","volume":"19","author":"Sieghart","year":"1994","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0105","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2174\/156802611794863562","article-title":"A closer look at the high affinity benzodiazepine binding site on GABAA receptors","volume":"11","author":"Sigel","year":"2011","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/274383a0","article-title":"GABAergic modulation of benzodiazepine binding site sensitivity","volume":"274","author":"TALLMAN","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2018.08.010_bib0115","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jlcr.3008","article-title":"PET radioligands targeting the brain GABAA\/benzodiazepine receptor complex","volume":"56","author":"Andersson","year":"2013","journal-title":"J. Label Compd. Radiopharm."},{"key":"10.1016\/j.neulet.2018.08.010_bib0120","first-page":"139","article-title":"Brain radioligands\u2013state of the art and new trends","volume":"45","author":"Halldin","year":"2001","journal-title":"Q. J. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.tips.2009.05.005","article-title":"PET Radiotracers: crossing the blood-brain barrier and surviving metabolism","volume":"30","author":"Pike","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"issue":"80","key":"10.1016\/j.neulet.2018.08.010_bib0130","article-title":"Effects of common anesthetic agents on [18F]flumazenil binding to the GABAA receptor","volume":"6","author":"Palner","year":"2016","journal-title":"EJNMMI Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0135","doi-asserted-by":"crossref","first-page":"4129","DOI":"10.1007\/s00213-015-3938-6","article-title":"Application of cross-species PET imaging to assess neurotransmitter release in brain","volume":"232","author":"Finnema","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2018.08.010_bib0140","first-page":"1","article-title":"Identification of positron emission tomography (PET) tracer candidates by prediction of the target-bound fraction in the brain","volume":"4","author":"Frid\u00e9n","year":"2014","journal-title":"Psychon. Bull. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0145","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.2967\/jnumed.109.063800","article-title":"A biomathematical modeling approach to central nervous system radioligand discovery and development","volume":"50","author":"Guo","year":"2009","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0150","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1021\/jm400312y","article-title":"Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand","volume":"56","author":"Zhang","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0155","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/syn.21920","article-title":"Estimating the effect of endogenous dopamine on baseline [11C]-(+)-PHNO binding in the human brain","volume":"70","author":"Caravaggio","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2018.08.010_bib0160","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/syn.20013","article-title":"In vivo vulnerability to competition by endogenous dopamine: comparison of the D2Receptor agonist radiotracer (-)-N-[11C]propyl-norapomorphine ([11C]NPA) with the D2Receptor antagonist radiotracer [11C]-raclopride","volume":"52","author":"Narendran","year":"2004","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2018.08.010_bib0165","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/syn.20549","article-title":"Occupancy of dopamine D2\/3 receptors in rat brain by endogenous dopamine measured with the agonist positron emission tomography radioligand [11C]MNPA","volume":"62","author":"Seneca","year":"2008","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2018.08.010_bib0170","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/ijnp\/pyx051","article-title":"Fenfluramine Reduces [11C]Cimbi-36 Binding to the 5-HT2A Receptor in the nonhuman primate Brain","volume":"20","author":"Yang","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0175","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/mp.2012.78","article-title":"Measuring endogenous changes in serotonergic neurotransmission in humans: A [11C] CUMI-101 PET challenge study","volume":"17","author":"Selvaraj","year":"2012","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0180","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1471-4159.1985.tb08739.x","article-title":"Modulation of [3H]diazepam binding in rat cortical membranes by GABAA agonists","volume":"44","author":"Wong","year":"1985","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0185","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/0014-2999(78)90031-6","article-title":"Influence of GABA receptor agonists and antagonists on the binding of 3H-diazepam to the benzodiazepine receptor","volume":"52","author":"Briley","year":"1978","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0190","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/0028-3908(78)90145-4","article-title":"Facilitation of benzodiazepine binding by sodium chloride and GABA","volume":"17","author":"Martin","year":"1978","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2018.08.010_bib0195","first-page":"233","article-title":"beta-Carbolines and benzodiazepine receptors: structure-activity relationships and pharmacologic activity","volume":"90","author":"Skolnick","year":"1982","journal-title":"Prog. Clin. Biol. Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0200","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1126\/science.6281892","article-title":"Interaction of convulsive ligands with benzodiazepine receptors","volume":"216","author":"Braestrup","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.neulet.2018.08.010_bib0205","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/294763a0","article-title":"Agonist and antagonist benzodiazepine receptor interaction in vitro","volume":"294","author":"M\u00f6hler","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2018.08.010_bib0210","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF00498510","article-title":"A three-state model of the benzodiazepine receptor explains the interactions between the benzodiazepine antagonist Ro 15-1788, benzodiazepine tranquilizers, beta-carbolines, and phenobarbitone","volume":"321","author":"Polc","year":"1982","journal-title":"Naunyn Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0215","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0014-2999(88)90461-X","article-title":"\u201cGABA shift\u201d in vivo: enhancement of benzodiazepine binding in vivo by modulation of endogenous GABA","volume":"148","author":"Miller","year":"1988","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0220","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0014-2999(87)90076-8","article-title":"[3H]Ro 15-1788 binding to benzodiazepine receptors in mouse brain in vivo: marked enhancement by GABA agonists and other CNS drugs","volume":"142","author":"Koe","year":"1987","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0225","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2174\/1568026616666160315142457","article-title":"Selected PET radioligands for ion channel linked neuroreceptor imaging: focus on GABA, NMDA and nACh receptors","volume":"16","author":"Kassenbrock","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0230","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1177\/0271678X16661339","article-title":"Quantification of [(11)C]Ro15-4513 GABAAalpha5 specific binding and regional selectivity in humans","volume":"37","author":"Myers","year":"2017","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.neulet.2018.08.010_bib0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.neuroimage.2016.12.038","article-title":"Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAAreceptors containing alpha5 subunits","volume":"152","author":"McGinnity","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2018.08.010_bib0240","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02516955","article-title":"High specific activity carbon-11 labelling of benzodiazepines: diazepam and flunitrazepam","volume":"56","author":"Maziere","year":"1980","journal-title":"J Radioanal Chem"},{"key":"10.1016\/j.neulet.2018.08.010_bib0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/280329a0","article-title":"Visualisation of 11C-Flunitrazepam displacement in the brain of the live baboon [19]","volume":"280","author":"Comar","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2018.08.010_bib0250","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0022-1139(00)82056-4","article-title":"Electrophilic and nucleophilic approaches to the synthesis of 3-fluorodiazepam","volume":"36","author":"Luxen","year":"1987","journal-title":"J. Fluor. Chem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0255","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jlcr.2580240108","article-title":"Syntheses of no-carrier-added (NCA) [18F]fluoroalkyl halides and their application in the synthesis of [18F]fluoroalkyl derivatives of neurotransmitter receptor active compounds","volume":"XXIV","author":"Shiue","year":"1987","journal-title":"J. Label Compd. Radiopharm."},{"key":"10.1016\/j.neulet.2018.08.010_bib0260","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0969-8051(94)00131-3","article-title":"Studies with [11C]alprazolam: an agonist for the benzodiazepine receptor","volume":"22","author":"Dobbs","year":"1995","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0265","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1046\/j.1471-4159.1994.62031102.x","article-title":"In-vivo high intrinsic efficacy of Triazolam \u2013 a positron emission tomography study in nonhuman-primates","volume":"62","author":"Bottlaender","year":"1994","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0270","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1002\/jlcr.2580221011","article-title":"Synthesis of 11C-suriclone","volume":"22","author":"Boullais","year":"1985","journal-title":"J. Label Compd. Radiopharm."},{"key":"10.1016\/j.neulet.2018.08.010_bib0275","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0014-2999(86)90422-X","article-title":"Imaging benzodiazepine receptors in man with [11C]suriclone by positron emission tomography","volume":"122","author":"James Frost","year":"1986","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0280","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0969-8051(93)90082-6","article-title":"Radioligands for PET studies of central benzodiazepine receptors and PK (Peripheral Benzodiazapine) binding sites-current status","volume":"20","author":"Pike","year":"1993","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0285","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1016\/j.bmc.2012.05.046","article-title":"Development of new carbon-11 labelled radiotracers for imaging GABAA- and GABAB-benzodiazepine receptors","volume":"20","author":"Moran","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.neulet.2018.08.010_bib0290","doi-asserted-by":"crossref","DOI":"10.1177\/1536012117731258","article-title":"the search for a subtype-selective PET imaging agent for the GABA Areceptor complex: evaluation of the radiotracer [11 C]ADO in nonhuman primates","volume":"16","author":"Lin","year":"2017","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.neulet.2018.08.010_bib0295","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.nucmedbio.2013.11.010","article-title":"Evaluation of a novel series of fluorine-18-labeled imidazobenzodiazepines as potential new positron emission tomography radioligands for the GABAA receptor","volume":"41","author":"Jackson","year":"2014","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0300","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.nucmedbio.2013.06.004","article-title":"Novel fluorine-18 PET radiotracers based on flumazenil for GABAA imaging in the brain","volume":"40","author":"Rodnick","year":"2013","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0305","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.2967\/jnumed.115.167403","article-title":"Ex Vivo Tracing of NMDA and GABA-A receptors in rat brain after traumatic brain injury using 18F-GE-179 and 18F-GE-194 autoradiography","volume":"57","author":"Lopez-Picon","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0310","article-title":"[11C]RO6899880, a novel agonist PET radioligand for the GABAA receptor","volume":"54","author":"Finnema","year":"2013","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0315","series-title":"10th Int Symp Funct Neurorecept Mapp Living Brain, Egmond Aan Zee, Netherlands","article-title":"PET evaluation of GABA sensitivity of benzodiazepine (BZD) site agonist [11C]RO6899880 in the monkey brain","author":"Finnema","year":"2015"},{"key":"10.1016\/j.neulet.2018.08.010_bib0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032443","article-title":"[11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels","volume":"7","author":"Frankle","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2018.08.010_bib0325","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neuroimage.2014.05.035","article-title":"Acute increases in synaptic GABA detectable in the living human brain: a [(1)(1)C]Ro15-4513 PET study","volume":"99","author":"Stokes","year":"2014","journal-title":"Neuroimage"},{"key":"10.1016\/j.neulet.2018.08.010_bib0330","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF02412110","article-title":"The effects of the benzodiazepine antagonist Ro 15-1788 on psychophysiological performance and subjective measures in normal subjects","volume":"89","author":"Higgitt","year":"1986","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2018.08.010_bib0335","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/npp.2008.104","article-title":"Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects","volume":"34","author":"Frankle","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2018.08.010_bib0340","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1176\/appi.ajp.2015.14081031","article-title":"In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients","volume":"172","author":"Frankle","year":"2015","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0345","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.nucmedbio.2016.11.003","article-title":"PET measurement of \u201cGABA shift\u201d in the rat brain: A preclinical application of bolus plus constant infusion paradigm of [18F]flumazenil","volume":"45","author":"Kim","year":"2017","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0350","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/syn.21780","article-title":"Influence of agonist induced internalization on [3H]Ro15-4513 binding-an application to imaging fluctuations in endogenous GABA with positron emission tomography","volume":"69","author":"Quelch","year":"2015","journal-title":"Synapse"},{"key":"10.1016\/j.neulet.2018.08.010_bib0355","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.brainres.2017.12.018","article-title":"ssssAcute in vivo effect of Valproic Acid on the GABAergic system in rat brain: A [11 C]Ro15-4513 microPET study","volume":"1680","author":"Bertelsen","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0360","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.tins.2004.07.002","article-title":"Diversity of inhibitory neurotransmission through GABA(A) receptors","volume":"27","author":"Mody","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1471-4159.2007.04454.x","article-title":"Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptors","volume":"102","author":"Mohler","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2018.08.010_bib0370","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031933","article-title":"Frontal GABA levels change during working memory","volume":"7","author":"Michels","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neulet.2018.08.010_bib0375","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/00004714-199806000-00010","article-title":"Enhanced selective attention after low-dose administration of the benzodiazepine antagonist flumazenil","volume":"18","author":"Smolnik","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0380","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1111\/bph.13850","article-title":"Cognitive deficits caused by prefrontal cortical and hippocampal neural disinhibition","volume":"174","author":"Bast","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0385","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/723184","article-title":"GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia","author":"Gonzalez-Burgos","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.neulet.2018.08.010_bib0390","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/nrn1648","article-title":"Cortical inhibitory neurons and schizophrenia","volume":"6","author":"Lewis","year":"2005","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0395","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.neuropharm.2011.01.022","article-title":"GABAergic interneuron origin of schizophrenia pathophysiology","volume":"62","author":"Nakazawa","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2018.08.010_bib0400","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0405","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.psychres.2015.07.077","article-title":"Association between GABA(A) receptor subunit polymorphisms and autism spectrum disorder (ASD)","volume":"229","author":"Sesarini","year":"2015","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0410","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neuropharm.2012.04.008","article-title":"The brain GABA-benzodiazepine receptor alpha-5 subtype in autism spectrum disorder: a pilot [(11)C]Ro15-4513 positron emission tomography study","volume":"68","author":"Mendez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2018.08.010_bib0415","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.braindev.2011.10.007","article-title":"Evaluation of the GABAergic nervous system in autistic brain: (123)I-iomazenil SPECT study","volume":"34","author":"Mori","year":"2012","journal-title":"Brain Dev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0420","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00213-009-1562-z","article-title":"The role of GABA(A) receptors in the acute and chronic effects of ethanol: a decade of progress","volume":"205","author":"Kumar","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.neulet.2018.08.010_bib0425","doi-asserted-by":"crossref","first-page":"573","DOI":"10.4161\/cib.16213","article-title":"What are we measuring with GABA magnetic resonance spectroscopy?","volume":"4","author":"Stagg","year":"2011","journal-title":"Commun. Integr. Biol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0430","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.biopsych.2005.04.044","article-title":"Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum","volume":"58","author":"Martinez","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0435","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/386830a0","article-title":"Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects","volume":"386","author":"Volkow","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neulet.2018.08.010_bib0440","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2018.08.010_bib0445","doi-asserted-by":"crossref","first-page":"8104","DOI":"10.1073\/pnas.97.14.8104","article-title":"Increased baseline occupancy of D2 receptors by dopamine in schizophrenia","volume":"97","author":"Abi-Dargham","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2018.08.010_bib0450","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/schbul\/sbt052","article-title":"Reduced binding potential of GABA-A\/benzodiazepine receptors in individuals at ultra-high risk for psychosis: An [18F]-fluoroflumazenil positron emission tomography study","volume":"40","author":"Kang","year":"2014","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.neulet.2018.08.010_bib0455","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.schres.2007.10.014","article-title":"GABAA\/Benzodiazepine receptor binding in patients with schizophrenia using [11C]Ro15-4513, a radioligand with relatively high affinity for \u03b15 subunit","volume":"99","author":"Asai","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0460","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4306\/pi.2013.10.1.75","article-title":"Is the GABA system Related to the social competence improvement effect of aripiprazole? An (18)F-fluoroflumazenil PET study","volume":"10","author":"Lee","year":"2013","journal-title":"Psychiatry Investig."},{"key":"10.1016\/j.neulet.2018.08.010_bib0465","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00259-009-1292-9","article-title":"Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results","volume":"37","author":"Klumpers","year":"2010","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neulet.2018.08.010_bib0470","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1001\/archneur.1995.00540270110027","article-title":"Positron emission tomography measures of benzodiazepine binding in Alzheimers disease","volume":"52","author":"Meyer","year":"1995","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0475","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03164869","article-title":"Preserved benzodiazepine receptors in Alzheimer\u2019s disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF","volume":"13","author":"Ohyama","year":"1999","journal-title":"Ann. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0480","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1093\/brain\/aws210","article-title":"Decreased carbon-11-flumazenil binding in early Alzheimer\u2019s disease","volume":"135","author":"Pascual","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.neulet.2018.08.010_bib0485","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1001\/archpsyc.1995.03950160008002","article-title":"Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics","volume":"52","author":"Akbarian","year":"1995","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0490","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1176\/appi.ajp.2011.11010052","article-title":"Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features","volume":"168","author":"Curley","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0495","doi-asserted-by":"crossref","first-page":"11839","DOI":"10.1523\/JNEUROSCI.1252-13.2013","article-title":"Conserved chromosome 2q31 conformations are associated with transcriptional regulation of GAD1 GABA synthesis enzyme and altered in prefrontal cortex of subjects with schizophrenia","volume":"33","author":"Bharadwaj","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0500","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0896-6273(00)00085-4","article-title":"Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex","volume":"28","author":"Mirnics","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neulet.2018.08.010_bib0505","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/sj.mp.4002011","article-title":"Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia","volume":"13","author":"Hashimoto","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0510","article-title":"CSF GABA is reduced in first-episode psychosis and associates to symptom severity","author":"Orhan","year":"2017","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0515","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1002\/hbm.23244","article-title":"Brain GABA levels across psychiatric disorders: a systematic literature review and meta-analysis of (1) H-MRS studies","volume":"37","author":"Schur","year":"2016","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.neulet.2018.08.010_bib0520","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2017.124","article-title":"Neuroimaging studies of GABA in schizophrenia: a systematic review with meta-analysis","volume":"7","author":"Egerton","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0525","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0006-3223(92)90039-3","article-title":"Low plasma gamma-aminobutyric acid levels in male patients with depression","volume":"32","author":"Petty","year":"1992","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0530","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1176\/ajp.141.12.1533","article-title":"CSF neurochemistry in depressed, manic, and schizophrenic patients compared with that of normal controls","volume":"141","author":"Gerner","year":"1984","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0535","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/da.20262","article-title":"Role of GABA in anxiety and depression","volume":"24","author":"Kalueff","year":"2007","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neulet.2018.08.010_bib0540","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.3174\/ajnr.A3965","article-title":"Molecular imaging for depressive disorders","volume":"35","author":"Lee","year":"2014","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0545","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1176\/appi.ajp.159.4.663","article-title":"Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors","volume":"159","author":"Sanacora","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0550","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopsych.2005.07.015","article-title":"Cortical gamma-aminobutyric acid concentrations in depressed patients receiving cognitive behavioral therapy","volume":"59","author":"Sanacora","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0555","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1001\/archpsyc.61.7.705","article-title":"Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression","volume":"61","author":"Sanacora","year":"2004","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0560","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.biopsych.2008.10.025","article-title":"Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder","volume":"65","author":"Price","year":"2009","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2018.08.010_bib0565","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1086\/301832","article-title":"Linkage-disequilibrium mapping of autistic disorder, with 15q11-13 markers","volume":"62","author":"Cook","year":"1998","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.neulet.2018.08.010_bib0570","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/j.neubiorev.2012.07.005","article-title":"GABA system dysfunction in autism and related disorders: from synapse to symptoms","volume":"36","author":"Coghlan","year":"2012","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0575","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1023\/A:1013238809666","article-title":"Density and distribution of hippocampal neurotransmitter receptors in autism: an autoradiographic study","volume":"31","author":"Blatt","year":"2001","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neulet.2018.08.010_bib0580","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.brainres.2010.09.021","article-title":"Reduced GABA(A) receptors and benzodiazepine binding sites in the posterior cingulate cortex and fusiform gyrus in autism","volume":"1380","author":"Oblak","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2018.08.010_bib0585","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1126\/science.1247190","article-title":"Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring","volume":"343","author":"Tyzio","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.neulet.2018.08.010_bib0590","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1523\/JNEUROSCI.2125-16.2017","article-title":"GABAergic interneuron differentiation in the basal forebrain is mediated through direct regulation of glutamic acid decarboxylase isoforms by Dlxhomeobox transcription factors","volume":"37","author":"Le TN","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0595","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/297153","article-title":"Alterations of GABAergic signaling in autism spectrum disorders","author":"Pizzarelli","year":"2011","journal-title":"Neural Plast."},{"key":"10.1016\/j.neulet.2018.08.010_bib0600","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism Spectrum disorders","volume":"309","author":"Christensen","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neulet.2018.08.010_bib0605","first-page":"1","article-title":"Increased GABAAreceptor binding in amygdala after prenatal administration of valproic acid to rats","author":"Bertelsen","year":"2016","journal-title":"Acta Neuropsychiatr."},{"key":"10.1016\/j.neulet.2018.08.010_bib0610","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2015.02.002","article-title":"A systematic review of molecular imaging (PET and SPECT) in autism spectrum disorder: current state and future research opportunities","volume":"52","author":"Zurcher","year":"2015","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neulet.2018.08.010_bib0615","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.neurobiolaging.2005.06.003","article-title":"Involvement of the GABAergic system in depressive symptoms of Alzheimer\u2019s disease","volume":"27","author":"Garcia-Alloza","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neulet.2018.08.010_bib0620","doi-asserted-by":"crossref","first-page":"10071","DOI":"10.1073\/pnas.1204606109","article-title":"Loss of functional GABAA receptors in the Alzheimer diseased brain","volume":"109","author":"Limon","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.neulet.2018.08.010_bib0625","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00088","article-title":"Drug development in Alzheimer\u2019s disease: the contribution of PET and SPECT","volume":"7","author":"Declercq","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neulet.2018.08.010_bib0630","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1007\/BF01367587","article-title":"Reduced cortical distribution volume of iodine-123 iomazenil in Alzheimer\u2019s disease as a measure of loss of synapses","volume":"23","author":"Soricelli","year":"1996","journal-title":"Eur. J. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0635","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/00003072-199909000-00004","article-title":"Comparison between cortical distribution of I-123 iomazenil and Tc-99m HMPAO in patients with Alzheimer\u2019s disease using SPECT","volume":"24","author":"Varrone","year":"1999","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.neulet.2018.08.010_bib0640","series-title":"Comparison of Iodine- 123-lomazenil SPECT and Technetium-99m-HMPAO-SPECT in Alzheimer's Disease","author":"Fukuchi","year":"2017"},{"key":"10.1016\/j.neulet.2018.08.010_bib0645","first-page":"1","article-title":"Tonic inhibition in dentate gyrus impairs long-term potentiation and memory in an Alzhiemer\u2019s disease model","volume":"5","author":"Wu","year":"2014","journal-title":"Nat. Commun."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018305408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394018305408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T08:57:14Z","timestamp":1751792234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394018305408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":129,"alternative-id":["S0304394018305408"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2018.08.010","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positron emission tomography imaging of the \u03b3-aminobutyric acid system","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2018.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}